If it's just enough to see us through to sales, as they mentioned in Fridays report, it will probably just be a relatively small placement with no shareholder participation.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025